Document Detail

Controlled-Release Basic Fibroblast Growth Factor for Peripheral Artery Disease: Comparison with Autologous Bone Marrow-Derived Stem Cell Transfer.
MedLine Citation:
PMID:  21810028     Owner:  NLM     Status:  Publisher    
Objective: We examined the safety and efficacy of controlled-release basic fibroblast growth factor (b-FGF) for peripheral artery disease (PAD), compared with autologous bone marrow mononuclear cell implantation (BMCI). Background: We recently developed a b-FGF-incorporated biodegradable hydrogel that enables slow-releasing drug delivery system. Methods: PAD patients were divided into a b-FGF group (n=10) and BMCI group (n=15). Injection of gelatin hydrogel containing 600 μg b-FGF or BMCI (0.4-5.1×10(10) cell) was performed. Visual analog pain scale (VAS), (99m)technetium-tetrofosmin (Tc-TF) scintigraphy, transcutaneous oxygen tension (TcPO(2)), and ankle-brachial index (ABI) were evaluated before and 4 weeks after each treatment, and 2-year prognosis was determined. Results: VAS (b-FGF 67±15 to 4±5, p<0.01, BMCI 67±42 to 5±9 mm, p<0.01) and TcPO(2) (b-FGF 16±14 to 47±17, p<0.01, BMCI 13±13 to 37±21 mmHg, p<0.01) were significantly improved in both groups. Tc-TF and ABI were not changed. Prognosis was similar between the groups (b-FGF 91%, BMCI 80%, NS). Conclusion: Controlled-release b-FGF is as safe as BMCI, and its efficacy appears to be comparable. Thus, this therapy may be an alternative to BMCI.
Gen Takagi; Masaaki Miyamoto; Shuhei Tara; Ikuyo Takagi; Hitoshi Takano; Masahiro Yasutake; Yasuhiko Tabata; Kyoichi Mizuno
Related Documents :
12132838 - Primary patellar tendon repair and early mobilization: results in an active-duty popula...
20844178 - Latissimus dorsi tendon transfer for irreparable rotator cuff tears: a modified techniq...
12002508 - The effect of increased stress on the patellar tendon.
1401798 - Index finger pollicization for congenital aplasia or hypoplasia of the thumb.
889518 - Swimmer's goggles for keratoconjunctivitis sicca.
8943108 - Gastroesophageal reflux: a determinant in the outcome of caustic esophageal burns.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-2
Journal Detail:
Title:  Tissue engineering. Part A     Volume:  -     ISSN:  1937-335X     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101466659     Medline TA:  Tissue Eng Part A     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
1 Division of Regenerative Medicine and Cardiology, Department of Internal Medicine, Nippon Medical School , Tokyo, Japan .
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Distribution of propranolol in periocular tissues: a comparison of topical and systemic administrati...
Next Document:  Scaffolds Based Bone Tissue Engineering: The Role of Chitosan.